Conmed Corp
F:EC8
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Conmed Corp
F:EC8
|
US |
|
P
|
Pinnacle West Capital Corp
LSE:0KIT
|
US |
|
Turning Point Brands Inc
NYSE:TPB
|
US |
|
Sensient Technologies Corp
NYSE:SXT
|
US |
|
Wasion Holdings Ltd
OTC:WSIOF
|
HK |
Wall St Price Targets
EC8 Price Targets Summary
Conmed Corp
According to Wall Street analysts, the average 1-year price target for EC8 is 48.71 EUR with a low forecast of 47.62 EUR and a high forecast of 50.78 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is EC8's stock price target?
Price Target
48.71
EUR
According to Wall Street analysts, the average 1-year price target for EC8 is 48.71 EUR with a low forecast of 47.62 EUR and a high forecast of 50.78 EUR.
What is the Revenue forecast for Conmed Corp?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 3 years is 4%.
What is the Gross Profit forecast for Conmed Corp?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 5%. The projected CAGR for the next 3 years is 7%.
What is the Operating Income forecast for Conmed Corp?
Projected CAGR
33%
Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 3 years is 33%.
What is the Pre-Tax Income forecast for Conmed Corp?
Projected CAGR
45%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 1%. The projected CAGR for the next 3 years is 45%.
What is the Net Income forecast for Conmed Corp?
Projected CAGR
52%
Over the last 13 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 3 years is 52%.
